Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules

This paper describes the optimization and validation of an analytical methodology for the determination of losartan potassium in capsules by HPLC using 25-1 fractional factorial and Doehlert designs. This multivariate approach allows a considerable improvement in chromatographic performance using fewer experiments, without additional cost for columns or other equipment. The HPLC method utilized potassium phosphate buffer (pH 6.2; 58 mmol L−1)–acetonitrile (65:35, v/v) as the mobile phase, pumped at a flow rate of 1.0 mL min−1. An octylsilane column (100 mm × 4.6 mm i.d., 5 μm) maintained at 35 °C was used as the stationary phase. UV detection was performed at 254 nm. The method was validated according to the ICH guidelines, showing accuracy, precision (intra-day relative standard deviation (R.S.D.) and inter-day R.S.D values <2.0%), selectivity, robustness and linearity (r = 0.9998) over a concentration range from 30 to 70 mg L−1 of losartan potassium. The limits of detection and quantification were 0.114 and 0.420 mg L−1, respectively. The validated method may be used to quantify losartan potassium in capsules and to determine the stability of this drug.